R

Resverlogix Corp.

24 employees

Resverlogix is a biopharmaceutical company, focused on the development of therapeutics in cardiovascular diseases and Alzheimer’s disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neurodegenerative diseases
Cardiovascular disease
Chronic Kidney Disease
Diabetes Mellitus
Drug Discovery
Health Care
Therapeutics
Atherosclerosis
Epigenetics
Drug Development
Biopharma
Muscular Dystrophy

Date founded

2001

Funding rounds raised

Total raised

$25M

from 2 investors over 2 rounds

R

Resverlogix Corp. raised $10M on June 6, 2018

Investors: Efung Capital

R

Resverlogix Corp. raised $25M on March 29, 2010

Investors: Yorkville Advisors

FAQ